About
MISO Chip develops a microfluidic platform for ex vivo testing of anticancer agents on patient-derived tumor explants that preserve the native tumor microenvironment, enabling improved preclinical drug development and translational oncology studies.
Explore MISO Chip's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.